SR0707 95TH GENERAL ASSEMBLY

SR0707 LRB095 21402 RPM 50733 r

SENATE RESOLUTION

WHEREAS, Bisphenol A (BPA) is found in many general plastics, such as food and drink packaging, baby bottles, thermoses, and other reusable plastic containers, and is used as an epoxy can liner, coating items such as food cans, bottles, and water supply pipes, and in the production of polycarbonate plastics; and

WHEREAS, Upon the request of the Commissioner of Food and Drugs, the U.S. Food and Drug Administration (FDA) formed an agency-wide BPA task force to facilitate the cross-agency review of current research and new information on BPA for all FDA regulated products; as a result of this review, the task force will make recommendations to the Commissioner regarding next steps; and

WHEREAS, Part of this evaluation will include the FDA Task Force reviewing the concerns presented in the National Toxicology Program Draft Brief published on April 14, 2008 by the U.S. National Institutes of Health and the concerns presented in the Canadian draft risk assessment released in April 2008; and

WHEREAS, The FDA has been reviewing the emerging literature on BPA on a continuous basis and has recently completed a review of the available biological fate data and 2 recently completed rodent multigeneration reproductive studies, and these studies did not indicate a safety concern for BPA at current exposure levels; in addition, the FDA is conducting a review of the data on neural and behavioral effects of BPA exposure; and

WHEREAS, The FDA will consider the research and positions of other transnational food safety organizations, including the 2 risk assessments for BPA conducted by the European Food Safety Authority Scientific Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food and the Japanese National Institute of Advanced Industrial Science and Technology; each of these documents considered the question of a possible low-dose effect and concluded that no current health risk exists for BPA at the current exposure level; and

WHEREAS, In January 2008, the United States House of Representatives Committee on Energy and Commerce began reviewing the use of bisphenol A in products intended for use by infants and children; and

WHEREAS, It is altogether fitting and proper and in the public interest for this Senate to urge the United States Food and Drug Administration to expedite their current review of bisphenol A in food containers, toys, and baby bottles; therefore, be it

RESOLVED, BY THE SENATE OF THE NINETY-FIFTH GENERAL ASSEMBLY OF THE STATE OF ILLINOIS, that we urge the United States Food and Drug Administration to expedite their current review of bisphenol A; and be it further

RESOLVED, That suitable copies of this resolution be delivered to the President and Vice President of the United States, the Commissioner of the United States Food and Drug Administration, and each member of the Illinois congressional delegation.